|
ASPH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.77379996749261E-09 |
| Normal-vs-Stage3 |
1.56874513379535E-13 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.522110E-02 |
| Stage1-vs-Stage3 |
4.867400E-01 |
| Stage1-vs-Stage4 |
5.509800E-01 |
| Stage2-vs-Stage3 |
2.126000E-01 |
| Stage2-vs-Stage4 |
2.119700E-02 |
| Stage3-vs-Stage4 |
3.112600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
8.47309999940649E-08 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
1.861590E-01 |
| Caucasian-vs-Asian |
5.322000E-01 |
| AfricanAmerican-vs-Asian |
4.601500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.722000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
3.63686858406709E-12 |
| Normal-vs-Age(81-100Yrs) |
3.96230000000442E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.401200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.812370E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.439600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.169400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.505800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.773600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.698200E-01 |
| Classical-VS-Follicular |
5.638700E-04 |
| Classical-VS-Other |
9.201600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.560600E-03 |
| Tall-VS-Other |
9.822600E-01 |
| Tall-VS-Normal |
1.668998272919E-12 |
| Follicular-VS-Other |
2.312600E-01 |
| Follicular-VS-Normal |
6.60400001351036E-09 |
| Other-VS-Normal |
3.95309999999816E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
3.497200E-03 |
|
|
